Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome.
作者信息
Jagdis Amanda, Vadas Peter
机构信息
Division of Allergy and Clinical Immunology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Division of Allergy and Clinical Immunology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
出版信息
Ann Allergy Asthma Immunol. 2014 Jul;113(1):115-6. doi: 10.1016/j.anai.2014.05.001.
PMID:24950847
Abstract
摘要
Zotero 插件